0001790072-19-000001.txt : 20191007
0001790072-19-000001.hdr.sgml : 20191007
20191007162007
ACCESSION NUMBER: 0001790072-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
EFFECTIVENESS DATE: 20191007
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SURMOUNT BIO, INC.
CENTRAL INDEX KEY: 0001790072
IRS NUMBER: 301205175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-350518
FILM NUMBER: 191141092
BUSINESS ADDRESS:
STREET 1: 711 DIMMEYDALE DRIVE
CITY: DEERFIELD
STATE: IL
ZIP: 60015
BUSINESS PHONE: 630-336-3511
MAIL ADDRESS:
STREET 1: 711 DIMMEYDALE DRIVE
CITY: DEERFIELD
STATE: IL
ZIP: 60015
D
1
primary_doc.xml
X0708
D
LIVE
0001790072
SURMOUNT BIO, INC.
MORTON MEDICAL RESEARCH BUILDING
310 EAST SUPERIOR AVENUE, FLOOR 7
CHICAGO
IL
ILLINOIS
60611
630-336-3541
DELAWARE
None
None
Corporation
true
2019
JAMES
SULLIVAN
C/O SURMOUNT BIO, INC., MORTON MEDICAL
RESEARCH BLDG, 310 E SUPERIOR AVE., FL 7
CHICAGO
IL
ILLINOIS
60611
Executive Officer
Director
Chief Executive Officer and Director
JONATHAN
SILVERSTEIN
11 RIVERSIDE DRIVE
APT. PHW2
NEW YORK
NY
NEW YORK
10023
Executive Officer
Director
President & Director
MONA
ASHIYA
C/O SURMOUNT BIO, INC., MORTON MEDICAL
RESEARCH BLDG, 310 E SUPERIOR AVE., FL 7
CHICAGO
IL
ILLINOIS
60611
Director
Other Technology
Decline to Disclose
- 06b
false
2019-09-20
false
true
true
Series A Preferred Stock
false
0
18000000
6000000
12000000
false
1
0
0
0
false
SURMOUNT BIO, INC.
/s/ James Sullivan
James Sullivan
Chief Executive Officer
2019-10-07